www.fdanews.com/articles/81528-glycofi-closes-oversubscribed-11-million-venture-round-new-board-members-appointed
GLYCOFI CLOSES OVERSUBSCRIBED $11 MILLION VENTURE ROUND; NEW BOARD MEMBERS APPOINTED
October 10, 2005
GlycoFi today announced the closing of an $11 million financing. The financing
was oversubscribed and was an extension of a $10 million series C financing
which closed in December of 2003. Participating in the additional investment
were existing investors including Polaris Venture Partners, SV Life Sciences,
Boston Millenia Partners, Fletcher Spaght Ventures, Village Ventures and Borealis
Ventures, as well as new investors International Biotechnology Trust, Peninsula
Equity Partners, and Eli Lilly & Company. The proceeds of the financing
will be used to take GlycoFi's protein optimization technology platform to the
next level of commercialization.
Business
Wire